Literature DB >> 11435107

Virulence factors of Candida albicans.

R A Calderone1, W A Fonzi.   

Abstract

Candidiasis is a common infection of the skin, oral cavity and esophagus, gastrointestinal tract, vagina and vascular system of humans. Although most infections occur in patients who are immunocompromised or debilitated in some other way, the organism most often responsible for disease, Candida albicans, expresses several virulence factors that contribute to pathogenesis. These factors include host recognition biomolecules (adhesins), morphogenesis (the reversible transition between unicellular yeast cells and filamentous, growth forms), secreted aspartyl proteases and phospholipases. Additionally, 'phenotypic switching' is accompanied by changes in antigen expression, colony morphology and tissue affinities in C. albicans and several other Candida spp. Switching might provide cells with a flexibility that results in the adaptation of the organism to the hostile conditions imposed not only by the host but also by the physician treating the infection.

Entities:  

Mesh:

Year:  2001        PMID: 11435107     DOI: 10.1016/s0966-842x(01)02094-7

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  347 in total

1.  Deletion of the two-component histidine kinase gene (CHK1) of Candida albicans contributes to enhanced growth inhibition and killing by human neutrophils in vitro.

Authors:  Antonella Torosantucci; Paola Chiani; Flavia De Bernardis; Antonio Cassone; Jose Antonio Calera; Richard Calderone
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 2.  Strategies for the identification of virulence determinants in human pathogenic fungi.

Authors:  R Alonso-Monge; F Navarro-García; E Román; B Eisman; C Nombela; J Pla
Journal:  Curr Genet       Date:  2003-02-08       Impact factor: 3.886

3.  Proteolytic cleavage of covalently linked cell wall proteins by Candida albicans Sap9 and Sap10.

Authors:  Lydia Schild; Antje Heyken; Piet W J de Groot; Ekkehard Hiller; Marlen Mock; Chris de Koster; Uwe Horn; Steffen Rupp; Bernhard Hube
Journal:  Eukaryot Cell       Date:  2010-11-19

4.  In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.

Authors:  Sharon C-A Chen; Chayanika Biswas; Robyn Bartley; Fred Widmer; Namfon Pantarat; Daniel Obando; Julianne T Djordjevic; David H Ellis; Katrina A Jolliffe; Tania C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

Review 5.  The spectrum of fungi that infects humans.

Authors:  Julia R Köhler; Arturo Casadevall; John Perfect
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

6.  Beta-1,2-mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype.

Authors:  P A Trinel; T Jouault; J E Cutler; D Poulain
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

7.  Characterization of Candida albicans colony-morphology mutants and their hybrids.

Authors:  A Novák; C Vágvölgyi; M Pesti
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

8.  Roles of Candida albicans Dfg5p and Dcw1p cell surface proteins in growth and hypha formation.

Authors:  Elisabetta Spreghini; Dana A Davis; Ryan Subaran; Michelle Kim; Aaron P Mitchell
Journal:  Eukaryot Cell       Date:  2003-08

Review 9.  Regulation of gene expression by ambient pH in filamentous fungi and yeasts.

Authors:  Miguel A Peñalva; Herbert N Arst
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

10.  In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans.

Authors:  Lingmei Sun; Shujuan Sun; Aixia Cheng; Xiuzhen Wu; Yu Zhang; Hongxiang Lou
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.